Business article - September 22, 2021
Proposed merge of Follicum and Coegin Pharma
The boards of Coegin Pharma and Follicum have assumed a merger plan in order to implement a merger of Coegin Pharma and Follicum through a limited company legal fusion. The fusion will be implemented by Follicum being absorbed by Coegin Pharma. Read more: Follicum pauses all of its development projects Coegin Pharma Coegin Pharma is […]
Financing - September 15, 2021
Follicum pauses all of its development projects
Following results from a phase 2 study of FOL-005, for the treatment of hair loss, the Board of the company decided to evaluate the company’s business strategy and long-term goals. The board of Follicum has now estimated that the company, in its current situation, will have difficulties in attracting financing for further operations of the […]
Clinical Trials - July 1, 2021
New study results from Follicum
Follicum reports revised data from a Phase IIa study of the tissue repairing peptide FOL-005 for the treatment of hair loss (alopecia). The revised data are based on an independent review that was conducted due to errors detected in the performance analysis presented by the company on May 6, 2021. The revised results show no […]
In a new job - May 11, 2021
Follicum appoints new CFO
The company announces that Jonas Edelswärd has been appointed as new Chief Financial Officer. He succeeds Fredrik Werner, who has decided to leave his position after 2 years in the company. Edelswärd took up his position on 10 May. “I am pleased to welcome Jonas Edelswärd as the new CFO. He knows Follicum well following […]
Business article - March 31, 2021
Follicum appoints new CEO and establishes new role as CSO
The company has recruited Dr. Kim Arvid Nielsen as new CEO, taking office on April 6, 2021. He has extensive experience in business development, investor relations and drug development from leading positions in both small and large pharmaceutical companies. At the same time, Follicum is establishing a new position as Chief Scientific Officer. The changes […]
Clinical Trials - March 24, 2021
Preclinical study results from Follicum
Follicum announces that significant progress has been made in the company’s development of new drug treatments for diabetes and other diseases. Within the framework of a preclinical research project, the interaction between one of Follicum’s tissue-repairing peptide families and a specific receptor has been characterized in detail. This will help accelerate continued optimization work aimed […]
